Valuation: Baxter International Inc.

Capitalization 9.09B 7.7B 7.1B 6.69B 12.48B 847B 12.68B 83.24B 32.58B 407B 34.09B 33.37B 1,444B P/E ratio 2026 *
28.1x
P/E ratio 2027 * 21.1x
Enterprise value 15.56B 13.18B 12.15B 11.46B 21.38B 1,450B 21.72B 143B 55.79B 696B 58.37B 57.15B 2,472B EV / Sales 2026 *
1.37x
EV / Sales 2027 * 1.3x
Free-Float
74.36%
Yield 2026 *
0.23%
Yield 2027 * 0.24%
1 day+0.06%
1 week+2.09%
Current month+4.76%
1 month+1.15%
3 months-13.60%
6 months-22.64%
Current year-7.90%
1 week 16.81
Extreme 16.81
18.05
1 month 15.73
Extreme 15.73
18.05
Current year 15.73
Extreme 15.73
22.41
1 year 15.73
Extreme 15.73
32.68
3 years 15.73
Extreme 15.73
50.21
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Director of Finance/CFO 52 2026-03-15
Chief Tech/Sci/R&D Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 75 2017-02-05
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Change 5d. change 1-year change 3-years change Capi.($)
+0.06%+2.09%-36.69%-59.12% 9.09B
+1.14%-1.93%-19.54%-2.31% 177B
-1.16%-1.75%+5.74%+7.92% 112B
-0.73%-2.26%+11.61%+90.02% 61.78B
-0.90%+2.73%+94.42%+107.13% 63.4B
-0.13%-1.00%-23.03%-39.13% 44.28B
+0.55%+8.10% - - 38.9B
-2.24%-6.47%-11.11%-46.81% 23.68B
-1.48%-1.57%+0.21%+18.75% 21.72B
+1.60%+6.06%+6.25%-36.57% 21.1B
Average -0.50%+1.29%+3.10%+4.43% 57.27B
Weighted average by Cap. -0.66%+0.10%+4.52%+17.03%

Financials

2026 *2027 *
Net sales 11.36B 9.62B 8.87B 8.37B 15.61B 1,059B 15.86B 104B 40.73B 508B 42.62B 41.72B 1,805B 11.61B 9.83B 9.07B 8.55B 15.95B 1,082B 16.21B 106B 41.63B 520B 43.56B 42.64B 1,845B
Net income 378M 320M 295M 278M 519M 35.19B 527M 3.46B 1.35B 16.89B 1.42B 1.39B 59.98B 438M 371M 342M 323M 602M 40.82B 611M 4.01B 1.57B 19.6B 1.64B 1.61B 69.59B
Net Debt 6.47B 5.48B 5.06B 4.77B 8.89B 603B 9.04B 59.3B 23.21B 290B 24.29B 23.78B 1,029B 5.99B 5.08B 4.68B 4.41B 8.23B 559B 8.37B 54.9B 21.49B 268B 22.48B 22.01B 952B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-04-15 17.60 $ +0.06% 4,005,704
26-04-14 17.59 $ -0.23% 5,761,419
26-04-13 17.63 $ +2.80% 12,110,226
26-04-10 17.15 $ -0.87% 3,536,516
26-04-09 17.30 $ +0.35% 5,440,026
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
17.60USD
Average target price
22.12USD
Spread / Average Target
+25.66%

Quarterly revenue - Rate of surprise